Terms: = Pancreatic cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825
16727 results:
1. A Humanized Patient-Derived Xenograft Model for pancreatic cancer.
Lundy J
Methods Mol Biol; 2024; 2806():91-100. PubMed ID: 38676798
[TBL] [Abstract] [Full Text] [Related]
2. Senolysis of gemcitabine-induced senescent human pancreatic cancer cells.
Hoque MM; Iida Y; Kotani H; Harada M
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2075. PubMed ID: 38662379
[TBL] [Abstract] [Full Text] [Related]
3. A pancreatic cancer organoid-in-matrix platform shows distinct sensitivities to T cell killing.
Lahusen A; Cai J; Schirmbeck R; Wellstein A; Kleger A; Seufferlein T; Eiseler T; Lin YN
Sci Rep; 2024 Apr; 14(1):9377. PubMed ID: 38654067
[TBL] [Abstract] [Full Text] [Related]
4. PAFAH1B3 is a KLF9 target gene that promotes proliferation and metastasis in pancreatic cancer.
Dong C; Yao J; Wu Z; Hu J; Sun L; Wu Z; Yan J; Yin X
Sci Rep; 2024 Apr; 14(1):9196. PubMed ID: 38649699
[TBL] [Abstract] [Full Text] [Related]
5. Critical roles of long noncoding RNA H19 in cancer.
Darmadi D; Chugaeva UY; Saleh RO; Hjazi A; Saleem HM; Ghildiyal P; Alwaily ER; Alawadi A; Alnajar MJ; Ihsan A
Cell Biochem Funct; 2024 Apr; 42(3):e4018. PubMed ID: 38644608
[TBL] [Abstract] [Full Text] [Related]
6. Discovery of YS-1 as a cell line of gastric inflammatory cancer-associated fibroblasts.
Numakura S; Kato M; Uozaki H
Mol Biol Rep; 2024 Apr; 51(1):542. PubMed ID: 38642200
[TBL] [Abstract] [Full Text] [Related]
7. Modelling the micro- and macro- environment of pancreatic cancer: from patients to pre-clinical models and back.
Lloyd EG; Henríquez JA; Biffi G
Dis Model Mech; 2024 Apr; 17(4):. PubMed ID: 38639944
[TBL] [Abstract] [Full Text] [Related]
8. Targeting KRAS in cancer.
Singhal A; Li BT; O'Reilly EM
Nat Med; 2024 Apr; 30(4):969-983. PubMed ID: 38637634
[TBL] [Abstract] [Full Text] [Related]
9. Talaromides A-C, Bioactive Cyclic Heptapeptides from
Cho Y; Park KH; Kim E; Kim S; Wang W; Choi H; Kang H
J Nat Prod; 2024 Apr; 87(4):1230-1234. PubMed ID: 38626456
[TBL] [Abstract] [Full Text] [Related]
10. Nuclear MAST4 Suppresses FOXO3 through Interaction with AKT3 and Induces Chemoresistance in pancreatic Ductal Carcinoma.
Fujiwara-Tani R; Sasaki T; Bhawal UK; Mori S; Ogata R; Sasaki R; Ikemoto A; Kishi S; Fujii K; Ohmori H; Sho M; Kuniyasu H
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612866
[TBL] [Abstract] [Full Text] [Related]
11. Adjustments of the Phytochemical Profile of Broccoli to Low and High Growing Temperatures: Implications for the Bioactivity of Its Extracts.
Šola I; Gmižić D; Pinterić M; Tot A; Ludwig-Müller J
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612494
[TBL] [Abstract] [Full Text] [Related]
12. Combined deletion of MEN1, ATRX and PTEN triggers development of high-grade pancreatic neuroendocrine tumors in mice.
Fuentes ME; Lu X; Flores NM; Hausmann S; Mazur PK
Sci Rep; 2024 Apr; 14(1):8510. PubMed ID: 38609433
[TBL] [Abstract] [Full Text] [Related]
13. Infection with SARS-CoV-2 can cause pancreatic impairment.
Deng W; Bao L; Song Z; Zhang L; Yu P; Xu Y; Wang J; Zhao W; Zhang X; Han Y; Li Y; Liu J; Lv Q; Liang X; Li F; Qi F; Deng R; Wang S; Xiong Y; Xiao R; Wang H; Qin C
Signal Transduct Target Ther; 2024 Apr; 9(1):98. PubMed ID: 38609366
[TBL] [Abstract] [Full Text] [Related]
14. Armored TGFβRIIDN ROR1-CAR T cells reject solid tumors and resist suppression by constitutively-expressed and treatment-induced TGFβ1.
Tran TM; Chand Thakuri BK; Nurmukhambetova S; Lee JJ; Hu P; Tran NQ; Steimle B; Dash P; Schneider D
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38609317
[TBL] [Abstract] [Full Text] [Related]
15. A glycolytic metabolite bypasses "two-hit" tumor suppression by BRCA2.
Kong LR; Gupta K; Wu AJ; Perera D; Ivanyi-Nagy R; Ahmed SM; Tan TZ; Tan SL; Fuddin A; Sundaramoorthy E; Goh GS; Wong RTX; Costa ASH; Oddy C; Wong H; Patro CPK; Kho YS; Huang XZ; Choo J; Shehata M; Lee SC; Goh BC; Frezza C; Pitt JJ; Venkitaraman AR
Cell; 2024 Apr; 187(9):2269-2287.e16. PubMed ID: 38608703
[TBL] [Abstract] [Full Text] [Related]
16. Genetic Signature of Human pancreatic cancer and Personalized Targeting.
Reshkin SJ; Cardone RA; Koltai T
Cells; 2024 Mar; 13(7):. PubMed ID: 38607041
[TBL] [Abstract] [Full Text] [Related]
17. ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation.
Huang Y; Chen D; Bai Y; Zhang Y; Zheng Z; Fu Q; Yi B; Jiang Y; Zhang Z; Zhu J
BMC Cancer; 2024 Apr; 24(1):452. PubMed ID: 38605349
[TBL] [Abstract] [Full Text] [Related]
18. Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancer.
Fu J; Ling J; Li CF; Tsai CL; Yin W; Hou J; Chen P; Cao Y; Kang Y; Sun Y; Xia X; Jiang Z; Furukawa K; Lu Y; Wu M; Huang Q; Yao J; Hawke DH; Pan BF; Zhao J; Huang J; Wang H; Bahassi EIM; Stambrook PJ; Huang P; Fleming JB; Maitra A; Tainer JA; Hung MC; Lin C; Chiao PJ
Nat Commun; 2024 Apr; 15(1):3149. PubMed ID: 38605037
[TBL] [Abstract] [Full Text] [Related]
19. Induction of islet autoimmunity to defective ribosomal product of the insulin gene as neoantigen after anti-cancer immunotherapy leading to autoimmune diabetes.
van Tienhoven R; Jansen DTSL; Park M; Williams JC; Larkin J; Quezada SA; Roep BO
Front Immunol; 2024; 15():1384406. PubMed ID: 38596681
[TBL] [Abstract] [Full Text] [Related]
20. NFKBIZ regulates NFκB signaling pathway to mediate tumorigenesis and metastasis of hepatocellular carcinoma by direct interaction with TRIM16.
Guo D; Zhang M; Wei T; Zhang X; Shi X; Tang H; Ding M; Li J; Zhang S; Guo W
Cell Mol Life Sci; 2024 Apr; 81(1):167. PubMed ID: 38581570
[TBL] [Abstract] [Full Text] [Related]
[Next]
